Progressive disease or protective immunity to Leishmania major infection: The result of a network of stimulatory and inhibitory interactions

Journal of Molecular Medicine

Volumn 76, Issue 6, 1998, Pages 372-390

  Etges, Robert ^a,b,f   Müller, Ingrid ^c,d,e,f  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF NOTRE DAME   (United States)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Cytokine; Interleukin 4 knockout mice; Leishmania major; Macrophage; T helper cell

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL CELL; ANTIGEN SPECIFICITY; CONTROLLED STUDY; GENE DISRUPTION; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; HYPOTHESIS; INFECTION PREVENTION; LEISHMANIA MAJOR; MOLECULAR INTERACTION; MOUSE; NONHUMAN; REVIEW; SPECIES DIFFERENCE; STRAIN DIFFERENCE;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; HOST-PARASITE RELATIONS; HUMANS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; T-LYMPHOCYTES;

EID: 0031966345     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050230     Document Type: Review

References (184)

1. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:787-793
2. Almeida RP, Barral-Netto M, DeJesus AMR, de Freitas LAR, Carvalho EM, Barral A (1996) Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/c mice. Am J Trop Med Hyg 54:178-184
3. Altes J, Salas A, Riera M, Udina M, Galmes A, Balanzat J, Ballesteros A, Buades J, Salva F, Villalonga C (1991) Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature. AIDS 5:201-207
4. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford N, Macduff BM, Anderson DM, Gimpel SD, Davis-Smith T, Maliszewski CR, Clark EA, Smith CA, Grabstein KH, Cosman D, Spriggs MK (1992) Molecular and biological characterization of a murine ligand for CD40. Nature 357:80-82
5. Assenmacher M, Schmitz J, Radbruch A (1994) Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-γ and in interleukin-4-expressing cells. Eur J Immunol 24:1097-1101
6. Badaro R, Carvalho EM, Rocha H, Queiroz AC, Jones TC (1986) Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet 1:647-649
7. Banchereau J, Bazan F, Blanchard D, Brière F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S (1994) The CD40 antigen and its ligand. Annu Rev Immunol 12:881-922
8. Barral-Netto M, Santana da Silva J, Barral A, Reed S (1995) Up-regulation of T helper 2 and down-regulation of T helper 1 cytokines during murine retrovirus-induced immunodeficiency syndrome enhances susceptibility of a resistant mouse strain to Leishmania amazonensis. Am J Pathol 146:635-642
9. Beebe AM, Mauze S, Schork NJ, Coffman RL (1997) Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity 6:551-557
10. Benin R, Mauel J, Sordat B (1979) Leishmania tropica: pathogenicity and in vitro macrophage function in strains of inbred mice. Exp Parasitol 48:81-91
11. Belosevic M, Finbloom DS, van der Meide PH, Slayter MV, Nacy CA (1989) Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates resistance of C3H/HeN mice to infection with Leishmania major. J Immunol 143:266-274
12. + thymocytes selected by MHC class I molecules. Science 263:1774-1778
13. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, Brutkiewicz RR (1995) CD1 recognition by mouse NK1+ T lymphocytes. Science 268:863-865
14. Berberich I, Shu GL, Clark EA (1994) Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B. J Immunol 153:4357-4366
15. Blackwell JM (1996) Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitol 112:S67-S74
16. Bogdan C, Gessner A, Röllinghoff M (1993) Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions. Immunobiology 189:356-396
17. Bogdan C, Gessner A, Solbach W, Röllinghoff M (1996) Invasion, control and persistence of Leishmania parasites. Curr Opin Immunol 8:517-525
18. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H (1992) Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257:539-542
19. Brown JA, Titus RG, Nabavi N, Glimcher LH (1996) Blockade of CD86 ameliorates Leishmania major infection by down-regulating the Th2 response. J Inf Dis 174:1303-1308
20. Campell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR (1996) CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283-289
21. Carreira PF, Maingon R, Ward RD, Noyes H, Ponce C, Belli A, Arana B, Zeledon R, Sousa OE (1995) Molecular techniques in the characterization of Leishmania isolates from Central America. Ann Trop Med Parasit 89 [Suppl]1:31-36
22. Carrera L, Gazzinelli RT, Badolato R, Hieny S, Müller W, Kühn R, Sacks DL (1995) Leishmania promastigotes selectively inhibit interleukin-12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med 183:515-526
23. Carter KC, Gallagher G, Baillie AJ, Alexander J (1989) The induction of protective immunity to Leishmania major in the BALB/c mouse by interleukin 4 treatment. Eur J Immunol 19:779-782
24. Carvalho EM, Barral-Neto M, Barral A, Broskyn CI, Bacellar O (1994) Immunoregulation in leishmaniasis. Ciência e Cultura (Journal of the Brazilian Association for the Advancement of Science) 46:441-445
25. Ceredig Rh, Lowenthal JW, Nabholz M, MacDonald RH (1985) Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature 314:98-100
26. Chatelain R, Varkila K, Coffman RL (1992) IL-4 induces a Th2 response in Leishmania major-infected mice. J Immunol 148:1182-1187
27. Coffman RL, Lebman DA, Rothman P (1993) Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 54:229-270
28. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon-gamma production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041-1048
29. + T cells asscociated with cure of human cutaneous leishmaniasis. Infect Immun 62:2614-2618
30. DaSilva R, Sacks DL (1987) Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation. Infect Immun 55:2802-2806
31. de Gorgolas M, Miles MA (1994) Visceral leishmaniasis and AIDS. Nature 372:734
32. De Tolla LJ, Scott PA, Farrell JP (1981) Single gene control of resistance to cutaneous leishmaniasis in mice. Immunogenetics 14:29-39
33. DeKruyff RH, Gienie RS, Umetsu DT (1997) Antigen-driven but not lipopolysaccaride-driven IL-12 production in macrophages requires triggering of CD40. J Immunol 158:359-366
34. Demant P, Lipoldova M, Svobodova M (1996) Resistance to Leishmania major in mice. Science 274:1392-1393
35. Doherty TM, Coffman RL (1996) Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice. Exp Parasitol 84:124-135
36. Engers HD, Bergquist R, Modabber F (1996) Progress on vaccines against parasites. Dev Biol Stand 87:73-84
37. H2 cytokines and help B cells. Science 260:1802-1805
38. Farrell JP, Kirkpatrick CE (1987) Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice. J Immunol 138:902-907
39. Ferrick DA, Schrenzel MD, Mulvania T, Hsieh B, Ferlin WG, Lepper W (1995) Differential production of interferon-γ and interleukin-4 in response to Th1-and Th2-stimulating pathogens by γ/δ T cells in vivo. Nature 373:255-257
40. Finkelman FD, Katona IM, Urban JF, Holmes J, Ohara J, Tung AS, Sample JV, Paul WE (1988) IL-4 is required to generate and sustain in vivo IgE responses. J Immunol 141:2335-2341
41. Fuzibet JG, Marty P, Taillan B, Bertrand F, Pras P, Pesce A, Le Fichoux Y, Dujardin P (1988) Is Leishmania infantum an opportunistic parasite in patients with human immunodeficiency virus? Arch Intern Med 18:1228
42. Gajewski TF, Fitch FW (1988) Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 140:4245-4252
43. Glaser TA, Mukkada AJ (1992) Proline transport in Leishmania donovani amastigotes: dependence on pH gradients and membrane potential. Mol Biochem Parasitol 51:1-8
44. Gorham JD, Güler ML, Steen RG, Mackey AJ, Duly MJ, Frederick K, Dietrich WF, Murphy KM (1996) Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc Natl Acad Sci USA 93:12467-12472
45. Green MS, Kark JD, Witztum E, Greenblatt CL, Spira DT (1983) Frozen stored Leishmania tropica vaccine: the effects of dose, route of administration and storage on the evolution of the clinical lesion. Two field trials in the Israel Defense Forces. Trans R Soc Trop Med Hyg 77:152-159
46. + T cell responses. Immunol Today 17:410-414
47. Grimaldi G Jr, Thes RB, McMahon-Pratt D (1989) A review of the geographic distribution and epidemiology of leishmaniasis in the new world. Am J Trop Med Hyg 41:687-725
48. Grimm F, Brun R, Jenni L (1991) Promastigote infectivity in Leishmania infantum. Parasitol Res 77:185-191
49. H1 cell development. Science 271:984-987
50. Hall LR, Titus RG (1995) Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production. J Immunol 155:3501-3506
51. Handel-Fernandez ME, Cheng X, Herbert LM, Lopez DM (1997) Down-regulation of IL-12, not a shift from a T helper-1 to a T helper-2 phenotype, is responsible for impaired IFN-γ production in mammary tumor-bearing mice. J Immunol 158:280-286
52. Handman E, Ceredig R, Mitchell GF (1979) Murine cutaneous leishmaniasis: Disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages. Aust J Exp Biol Med Sci 57:9-29
53. Heinzel FP, Rerko RM, Ahmed F, Pearlman E (1995) Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J Immunol 155:730-739
54. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM (1989) Reciprocal expression of interferon-γ or interleukin 4 during the resolution or progression of murine leishmaniasis. J Exp Med 169:59-72
55. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc Natl Acad Sci USA 88:7011-7015
56. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK (1993) Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177:1505-1509
57. Hermann P, Blanchard D, de Saint-Vis B, Fossiez F, Gaillard C, Vanbervliet B, Brière F, Banchereau J, Galizzi JP (1993) Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes. Eur J Immunol 23:961-964
58. Hjulström S, Landin A, Jansson L, Holmdahl R, Heyman B (1995) No role of interleukin-4 in CD23/IgE-mediated enhancement of the murine antibody response in vivo. Eur J Immunol 25:1469-1472
59. Howard JC, Hale G, Liew FY (1981) Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica. J Exp Med 153:557-568
60. Hsieh C-S, Macatonia SE, O'Garra A, Murphy KM (1995) T cell genetic background determines default T helper phenotype development in vitro. J Exp Med 181:713-721
61. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549
62. Huber M, Rutherford A, Meister W, Weiss A, Röllinghoff M, Lohoff M (1996) TcR-and IL-1-mediated co-stimulation reveals an IL-4-independent way of Th2 cell proliferation. Int Immunol 8:1257-1263
63. Huszar M, Shor R, Trau H, Gazit E, Paswell JH (1987) The T cell phenotype in the lesion of patients with cutaneous leishmaniasis. Clin Exp Dermatol 12:103-107
64. Jordan WS (1989) Impediments to the development of additional vaccines: vaccines against important diseases that will not be available in the next decade. Rev Infect Dis 11: S603-S612
65. Julia V, Rassoulzadegan M, Glaichenhaus N (1996) Resistance to Leishmania major induced by tolerance to a single antigen. Science 274:421-423
66. Kalinski P, Hilkens CMU, Wierenga EA, van der Pouw-Kraan TCTM, van Lier RA, Bos JD, Kapsenberg ML, Snijdewint FGM (1995) Functional maturation of human naive T helper cells in the absence of accessory cells. J Immunol 154:3753-3760
67. Kamanaka M, Yu P, Yasui T, Yoshida K, Kawabe T, Horii T, Kishimoto T, Kikutani H (1996) Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275-281
68. Kanagawa O, Vaupel BA, Gayama S. Köhler G, Kopf M (1993) Resistance of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Science 262:240-242
69. Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T, Kikutani H (1994) The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167-178
70. Kaye PM (1995) Costimulation and the regulation of antimicrobial immunity. Immunol Today 16:423-427
71. Kaye PM, Curry AJ, Blackwell JM (1991) Differential production of Th1-and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J Immunol 146:2763-2770
72. Kelso A (1995) Th1 and Th2 subsets: paradigms lost? Immunol Today 16:371-379
73. + T cells actived in a T helper type 2-like response in vivo. Eur J Immunol 25:1168-1175
74. + T cells. Eur J Immunol 26:3163-3169
75. + T cells. Eur J Immunol 25:587-595
76. Kopf M, Brombacher F, Köhler G, Kienzle G, Widmann K-H, Lefrang K, Humborg C, Ledermann B, Solbach W (1996) IL-4-deficient BALB/c mice resist infection with Leishmania major. J Exp Med 184:1127-1136
77. Kopf M, LeGros G, Bachmann M, Lamers MC, Bluethmann H, Köhler G (1993) Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245-248
78. Kröpf P, Etges R, Schöpf L, Chung C, Sypek J, Müller I (1997) Characterization of T cell-mediated responses in non-healing and healing Leishmania major infections in the absence of endogenous interleukin-4. J Immunol in press:
79. Kühn R, Rajewsky K, Müller W (1991) Generation and analysis of interleukin-4 deficient mice. Science 254:707-710
80. Lanzaro GC, Osterovska K, Herrero MV, Lawyer PG, Warburg A (1993) Lutzomyia longipalpis is a species complex: genetic divergence and interspecific hybrid sterility among three populations. Am J Trop Med Hyg 48:839-847
81. Lanzaro GC, Warburg A (1995) Genetic variability in phlebotomine sandflies: possible implications for leishmaniasis epidemiology. Parasitol Today 11:151-154
82. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6:541-549
83. + T cells which are NK1.1 . Eur J Immunol 25:3298-3307
84. Leal LMCC, Moss DW, Kuhn R, Müller W, Liew FY (1993) Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur J Immunol 23:566-569
85. Lezama-Davila CM, Williams DM, Gallagher G, Alexander J (1992) Cytokine control of Leishmania infection in the BALB/c mouse: enhancement and inhibition of parasite growth by local administration of IL-2 or IL-4 is species and time dependent. Parasite Immunol 14:37-48
86. + T cells in leishmaniasis. Immunol Today 10:40-45
87. Liew FY, Li Y, Moss D, Parkinson C, Rogers MV, Moncada S (1991) Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur J Immunol 21:3009-3014
88. Liew FY, O'Donnell CA (1993) Immunology of leishmaniasis. Adv Parasitol 32:162-259
89. Magill AJ, Grögl M, Gasser RA, Wellington S, Oster CN (1993) Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 328:1383-1387
90. Maruo S, Oh-hora M, Ahn H-J, Onu S, Wysocka M, Kaneko Y, Yagita H, Okumura K, Kikutani H, Kishimoto T, Kobayashi M, Hamaoka T, Trinchieri G, Fujiwara H (1997) B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions. J Immunol 158:120-126
91. Marx J (1996) Leishmania susceptibility puzzle gets another twist. Science 271:912-913
92. Mattner F, Di Padova K, Alber G (1997) Interleukin-12 is indispensable for protective immunity against Leishmania major. Infect Immun (in press)
93. Melby PC (1991) Experimental leishmaniasis in humans: review. Rev Infect Dis 13:1009-1017
94. Mendonça SCF, De Luca PM, Mayrink W, Restom TG, Conceição-Silva F, DaCruz AM, Bertho AL, Da Costa CA, Genaro O, Toledo VPCP, Coutinho SG (1995) Characterization of human T lymphocyte-mediated immune response induced by a vaccine against American tegumentary leishmaniasis. Am J Trop Med Hyg 53:195-201
95. Menon JN, Bretscher PA (1996) Characterization of the immunological state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge. Eur J Immunol 26:243-249
96. Miralles GD, Stoeckle MY, McDermott DF, Finkelman FD, Murray HW (1994) Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infect Immun 62:1058-1063
97. Mitchell GF (1983) Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major. J Immunogenet 10:395-412
98. Mitchell GF, Curtis JM, Handman E (1981) Resistance to cutaneous leishmaniasis in genetically susceptible BALB/c mice. Aust J Exp Biol Med Sci 59:555-565
99. Mitchell GF, Curtis JM, Scollay R, Handman E (1981) Resistance and abrogation of resistance to cutaneous leishmaniasis in reconstituted BALB/c nude mice. Aust J Exp Biol Med Sci 59:539-554
100. Mock B, Blackwell J, Hilgers J, Potter M, Nacy C (1993) Genetic control of Leishmania major infection in congenic, recombinant inbred and F2 populations of mice. Eur J Immunogenetics 20:335-348
101. Modabber F (1990) Development of vaccines against leishmaniasis. Scand J Infect Dis Suppl 76:72-78
102. Modabber F (1995) Vaccines against leishmaniasis. Ann Trop Med Parasitol 89 [Suppl]:83-88
103. Molina IJ, Huber BT (1991) Regulation of macrophage activation markers by IL-4 and IFN-γ is subpopulation-specific. Cell Immunol 134:241-248
104. Morawetz RA (1994) Technical comments: resistance to murine acquired immunodeficiency syndrome (MAIDS). Science 265:264-266
105. Morawetz RA, Gabriele L, Rizzo LV, Noben-Trauth N, Kühn R, Rajewski K, Müller W, Doherty M, Finkelman F, Coffman RL, Morse HC (1996) Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig) E in the mouse. J Exp Med 184:1651-1661
106. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted protein. J Immunol 136:2348-2357
107. Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173
108. Mougneau E, Altare F, Wakil AE, Zheng S, Coppola T, Wang Z, Waldmann R, Locksley RM, Glaichenhaus N (1995) Expression cloning of a protective Leishmania antigen. Science 268:563-566
109. Murray HW, Miralles GD, Stoeckle MY, McDermott DF (1993) Role and effect of IL-2 in experimental visceral leishmaniasis. J Immunol 151:929-938
110. Müller I (1992) Role of T cell subsets during the recall of immunologic memory to Leishmania major. Eur J Immunol 22:3063-3069
111. Müller I, Freudenberg M, Kropf P, Kiderlen A, Galanos C (1997) Leishmania major infection in C57BL/10 mice differing at the Lps locus: a new non-healing phenotype. Med Microbiol Immunol (in press)
112. Müller I, Fruth U, Louis JA (1992) Immunobiology of experimental leishmaniasis. Med Microbiol Immunol 181:1-12
113. Müller I, Garcia-Sanz J, Titus R, Behin R, Louis J (1989) Analysis of the cellular parameters of the immune responses contributing to resistance and susceptibility of mice to infection with the intracellular parasite, Leishmania major. Immunol Rev 112:95-113
114. + T cells. Infect Immun 61:3730-3738
115. + T cells following secondary infection of mice immune to Leishmania major. Infect Immun 62:2575-2581
116. + T cell clones recognizing antigen(s) associated with live parasites. Eur J Immunol 19:865-871
117. +T cells. Int Immunol 3:587-597
118. Müller I, Titus R, Caldumbide I, Louis J (1989) T cell responses in resistance and susceptibility to experimental leishmaniasis. In: McAdam K (ed) Frontiers of infectious diseases: new strategies in parasitology. Churchill Livingston, London, pp 158-175
119. Nabors GS, Afonso LCC, Farrell JP, Scott P (1995) Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and pentostam. Proc Natl Acad Sci 92:3142-3146
120. Nabors GS, Farrell JP (1994) Depletion of Interleukin-4 in BALB/c mice with established Leishmania major infections increases with the efficacy of antimony therapy and promotes Th-1 like responses. Infect Immun 62:5498-5504
121. Nabors GS, Farrell JP (1994) Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response. Infect Immun 62:3655-3662
122. Neal RA (1984) Leishmania major: culture media, mouse strains, and promastiogte virulence and infectivity. Exp Parasitol 57:269-273
123. Noben-Trauth N, Kröpf P, Müller I (1996) Susceptibility to Leishmania major infection in interleukin-4 deficient mice. Science 271:987-990
124. Noben-Trauth N, Köhler G, Bürki K, Ledermann B (1996) Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic res 5:487-491
125. Nolan TJ, Herman R (1985) Effects of long-term in vitro cultivation on Leishmania donovani promastigotes. J Protozool 32:70-75
126. PAHO Communicable Disease Program (1994) Leishmania-sis in the Americas. Epidem Bull /PAHO 15 (3):8-13
127. Pascale JM, DeCarreira P, Ljungstruöm I, Sousa OE, Örn A (1994) Recurrence in localized cutaneous leishmaniasis: clinical and immunological factors. Chron Derm 4:749-765
128. Pearce EJ, Reiner SL (1995) Induction of Th2 responses in infectious diseases. Curr Opin Immunol 7:497-504
129. Preston PM, Dumonde DC (1976) Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. Clin Exp Immunol 23:126-138
130. Ranger AM, Prabhu Das M, Kuchroo VK, Glimcher LH (1996) B7-2 (CD86) is essential for the development of IL-4 producing Tcells. Int Immunol 8:1549-1560
131. Reiner SL, Locksley RM (1995) The regulation of immunity to Leishmania major. Annu Rev Immunol 13:151-177
132. + T cells during initiation of infection. J Exp Med 179:447-456
133. Richards ML, Katz DH (1997) Analysis of the promoter elements necessary for IL-4 and anti-CD40 antibody induction of murine FcεRII (CD23). J Immunol 158:263-272
134. Roberts LJ, Baldwin TM, Curtis JM, Handman E, Foote SJ (1997) Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9. J Exp Med 185:1705-1710
135. Romagnani S (1994) Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227-257
136. Rosenberg EV (1996) How T cells count. Science 273:78-79
137. Rothe M, Arma V, Dixit VM, Goeddel DV (1995) TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269:1424-1427
138. + T cells producing IL-2 or IL-4. J Immunol 148:1031-1036
139. Sabin EA, Kopf MA, Pearce EJ (1996) Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils. J Exp Med 184:1871-1878
140. Sacks DL, Da Silva RP (1987) The generation of infective stage Leislimania major promastigotes is associated with the cell-surface expression and release of a developmentally regulated glycolipid. J Immunol 139:3099-3106
141. Sacks DL, Hieny S, Sher A (1985) Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J Immunol 135:564-569
142. Sacks DL, Perkins PV (1984) Identification of an infective stage of Leishmania promastigotes. Science 223:1417-1419
143. + T cells secreting Th1 or Th2 cytokines. Immunity 2:271-279
144. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM (1990) Cure of murine leishmaniasis with anti-interleukin-4 monoclonal antibody. Evidence for a T-cell-dependent, interferon-γ-independent mechanism. J Exp Med 171:115-127
145. Samuelson J, Lerner E, Tesh R, Titus R (1991) A mouse model of Leishmania braziliensis infection produced by coinjection with sand fly salvia. J Exp Med 173:49-54
146. Satoskar A, Bluethmann H, Alexander J (1995) Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect Immun 63:4894-4899
147. + T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 178:567-577
148. + T cells. Eur J Immunol 24:343-347
149. Scott P (1996) Th cell development and regulation in experimental cutaneous leishmaniasis. In: Romagnani S (ed) Th1 and Th2 cells in health and disease. Karger, Basel, pp 98-113
150. Scott P, Eaton A, Gause WC, diZhou X, Hondowicz B (1996) Early IL-4 production does not predict susceptiblity to Leishmania major. Exp Parasitol 84:178-187
151. + T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev 112:161-182
152. Scott PA, Farrell JP (1982) Experimental cutaneous leishmaniasis: disseminated leishmaniasis in genetically susceptible and resistant mice. Am J Trop Med Hyg 31:230-238
153. + T cells. Annu Rev Immunol 12:635-673
154. Sha WC, Liou HC, Tuomanen EI, Baltimore D (1995) Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80:321-330
155. Shankar AH, Titus RG (1995) T cell and non-T cell compartments can independently determine resistance to Leishmania major. J Exp Med 181:845-855
156. Sher A, Ahmed R (1995) Immunity to infection. Regulation of innate and adaptive responses to infection: new avenues and angles. Curr Opin Immunol 7:471-473
157. Soong L, Xu J-C, Grewal IS, Kima P, Sun J, Longley BJ Jr, Ruddle NH, McMahon-Pratt D, Flavell R (1996) Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263-273
158. Stenger S, Donhauser N, Thuring H, Röllinghoff M, Bogdan C (1996) Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 183:1501-1514
159. Stenger S, Thuring H, Röllinghoff M, Bogdan C (1994) Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med 180:783-793
160. Stüber E, Strober W, Neurath M (1996) Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of Th1 cells through the inhibition of interleukin 12 secretion. J Exp Med 183:693-698
161. + T cell response. J Exp Med 181:961-971
162. Sypek JP, Chung CL, Mayor SEH, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 177:1797-1802
163. Tartakovsky B, Finnegan A, Muegge K, Brody DT, Kovacs EJ, Smith MR, Berzofsky JA, Young HA, Durum SK (1988) IL-1 is an automne growth factor for T cell clones. J Immunol 141:3863-3867
164. Tesh RB (1995) Control of zoonotic visceral leishmaniasis: is it time to change strategies? Am J Trop Med Hyg 52:287-292
165. Titus RG, Ceredig R, Cerottini JC, Louis JA (1985) Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically susceptible BALB/c mice. J Immunol 135:2108-2114
166. + Leishmania major specific T cell lines or clones which secrete interferon-γ and mediate parasite-specific delayed-type hypersensitivity. Eur J Immunol 21:559-567
167. Tripp CS, Wolf SF, Unanue ER (1993) Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 90:3725-3729
168. Turk JL, Bryceson ADM (1971) Immunological phenomena in leprosy and related diseases. Adv Immunol 13:209-266
169. Varkila K, Chatelain R, Leal LMCC, Coffman RL (1993) Reconstitution of C.B.-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection. Eur J Immunol 23:262-268
170. Viola A, Lanzavecchia A (1996) T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104-106
171. von der Weid T, Kopf M, Köhler G, Langhorne J (1994) The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur J Immunol 24:2285-2293
172. + effector cells default to the Th2 pathway in interferon g deficient mice infected with Leishmania major. J Exp Med 179:1367-1371
173. Warburg A, Saraiva E, Lanzaro GC, Titus RG, Neva F (1994) Saliva of Lutzomyia longipalpis sibling species differs in its composition and capacity to enhance leishmaniasis. Phil Trans R Soc London B 345:223-230
174. Warburg A, Schlein Y (1986) The effect of post-bloodmeal nutrition of Phlebotomus papatasi on the transmission of Leishmania major. Am J Trop Med Hyg 36:926-930
175. Wei X, Charles IG, Smith A, Ure J, Feng G, Huang F, Xu D, Müller W, Moncada S, Liew FY (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411
176. Wershil BK, Theodos CM, Galli SJ, Titus RG (1994) Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J Immunol 152: 4563-4571
177. Wolfram M, Fuchs M, Wiese M, Stierhof Y-D, Overath P (1996) Antigen presentation by Leishmania mexicana infected macrophages: activation of helper T cells by a model parasite antigen secreted into the parasitophorous vacuole or expressed on the amastigote surface. Eur J Immunol 26:3153-3162
178. World Health Organization (1995) 12th Programme Report. Leishmaniasis. In: Tropical disease research: 20 years of progress. World Health Organization. Geneva, pp 135-146
179. Xu X, Sun Y, Hoey T (1996) Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273:794-797
180. Yu P, Kosco-Vilbois M, Richards M, Köhler G, Lamers MC (1994) Negative feedback regulation of IgE synthesis by murine CD23. Nature 369:753-756
181. Zeledon R, Hidalgo H, Viquez A, Urbina A (1989) Atypical cutaneous leishmaniasis in a semiarid region of north-west Costa Rica. Trans R Soc Trop Med Hyg 83:786
182. Zilberstein D, Dwyer DM (1985) Protonmotive force-driven active transport of D-glucose and L-proline in the protozoan parasite Leishmania donovani. Proc Natl Acad Sci USA 82:1716-1720
183. Zubiaga AM, Mu-oz E, Huber BT (1991) Production of IL-1α by activated Th type 2 cells. Its role as an autocrine growth factor. J Immunol 146:3849-3856
184. Zurawski G, de Vries JE (1994) Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 15:19-26